2006
DOI: 10.2174/138955706778195216
|View full text |Cite
|
Sign up to set email alerts
|

Anti-tumor Therapeutic Molecules that Target the Programmed Cell Death Machinery

Abstract: Apoptosis is a process that governs the elimination of unwanted, damaged, or infected cells in most organisms. Defects in its execution are associated with several diseases, including cancer. Herein, we discuss novel molecules with potential anti-tumor activity that target components of the apoptotic machinery, specifically Bcl-2 proteins, IAPs and caspases.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 61 publications
0
2
0
Order By: Relevance
“…Apoptosis is a result of cell cycle arrest and its rate may be used to predict the cytotoxicity of anti-cancer agents (36,37). In the presence of pro-death stimuli, including cytotoxic agents, cells respond by initiating programmed death, characterized by certain detectable morphological alterations, including nuclear fragmentation, chromatin condensation, cell shrinkage, membrane blebbing and formation of apoptotic bodies (26,38). The aforementioned morphological alterations serve as indicators of cell apoptosis.…”
Section: Discussionmentioning
confidence: 99%
“…Apoptosis is a result of cell cycle arrest and its rate may be used to predict the cytotoxicity of anti-cancer agents (36,37). In the presence of pro-death stimuli, including cytotoxic agents, cells respond by initiating programmed death, characterized by certain detectable morphological alterations, including nuclear fragmentation, chromatin condensation, cell shrinkage, membrane blebbing and formation of apoptotic bodies (26,38). The aforementioned morphological alterations serve as indicators of cell apoptosis.…”
Section: Discussionmentioning
confidence: 99%
“…It is generally assumed that tumor suppression is at least in part due to p53induced apoptosis and that, during tumor formation, a selection for p53 loss of function takes place [3]. These anti-apoptotic proteins are often over-expressed as a result of chromosomal translocations in various tumors, for instance, leukemia, lymphoma, and breast cancer [6,7]. Contrarily, the anti-apoptotic protein Bcl-2 and some Bcl-2-related proteins such as Bcl-X L are *Address correspondence to this author at Biological Chemistry, Leiden University; Einsteinweg 55, 2333 CC Leiden, The Netherlands.…”
Section: Imbalance Of Rescue and Apoptosismentioning
confidence: 99%